CCDC86 Antibody
- 
								中文名稱:CCDC86兔多克隆抗體
- 
								貨號:CSB-PA004753GA01HU
- 
								規(guī)格:¥3,900
- 
								其他:
產(chǎn)品詳情
- 
											Uniprot No.:
- 
											基因名:
- 
											別名:CCDC86 antibody; CYCLON antibody; Coiled-coil domain-containing protein 86 antibody; Cytokine-induced protein with coiled-coil domain antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human,Mouse,Rat
- 
											免疫原:Human CCDC86
- 
											免疫原種屬:Homo sapiens (Human)
- 
											抗體亞型:IgG
- 
											純化方式:Antigen Affinity purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
- 
											產(chǎn)品提供形式:Liquid
- 
											應(yīng)用范圍:ELISA,WB
- 
											Protocols:
- 
											儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點詳情
- 
											基因功能參考文獻(xiàn):- Cyclon/CCDC68 levels correlate with the clinical presentation of relapsed schizophrenia PMID: 23439384
- cyclon gene encodes a phosphorylated nuclear protein consisting of repetitive sequences in the amino-terminus and a coiled-coil domain in the carboxyl-terminus PMID: 17300783
 
- 
											亞細(xì)胞定位:Nucleus.
- 
											數(shù)據(jù)庫鏈接:
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
 













 
         
           
  
          